Annals of vascular surgery · 2026
Outcomes of Partial Endograft Explantation for Noninfectious Failures after Endovascular Aneurysm Repair: A Retrospective Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Isomura Shogo, Ohno Hideaki, Toyoda Yasuyuki, Matsumura Yu, Yamaki Fumitaka
Аннотация
BACKGROUND: Late open conversion (LOC) after endovascular aneurysm repair (EVAR) remains challenging, and an optimal surgical strategy has not yet been established. We evaluated the clinical outcomes and mid- to long-term durability of surgical reconstruction using a standardized strategy for partial explantation in a regional, real-world setting.
METHODS: We retrospectively reviewed data from 29 consecutive patients who underwent LOC for noninfectious EVAR failure between July 2013 and December 2025. Clinical outcomes were evaluated using follow-up data available through April 2026. The primary surgical strategy consisted of elective conversion, infrarenal clamping, and partial endograft explantation with "neo-neck" creation whenever feasible.
RESULTS: Elective LOC was performed for progressive aneurysm sac enlargement in 27 patients (93.1%); type II endoleak was the predominant preoperative finding (n = 16; 55.2%). The remaining 2 patients underwent urgent LOC for bilateral endograft limb thrombosis with lower-extremity ischemia (n = 1) or symptomatic sac enlargement with suspected impending rupture (n = 1). Partial explantation was performed in 28 patients (96.6%). The 30-day mortality rate was 6.9% (n = 2). During the median follow-up period of 44 (range, 0-152) months, no late aortic-related events attributable to the retained endograft components were observed. The estimated 5-year overall survival and freedom from aortic-related events were 88.9% and 93.1%, respectively.
CONCLUSION: The standardized partial explantation strategy was feasible in selected patients undergoing LOC for noninfectious EVAR failure and was associated with acceptable perioperative outcomes and mid- to long-term reconstructive durability even in a low-volume, real-world setting.
METHODS: We retrospectively reviewed data from 29 consecutive patients who underwent LOC for noninfectious EVAR failure between July 2013 and December 2025. Clinical outcomes were evaluated using follow-up data available through April 2026. The primary surgical strategy consisted of elective conversion, infrarenal clamping, and partial endograft explantation with "neo-neck" creation whenever feasible.
RESULTS: Elective LOC was performed for progressive aneurysm sac enlargement in 27 patients (93.1%); type II endoleak was the predominant preoperative finding (n = 16; 55.2%). The remaining 2 patients underwent urgent LOC for bilateral endograft limb thrombosis with lower-extremity ischemia (n = 1) or symptomatic sac enlargement with suspected impending rupture (n = 1). Partial explantation was performed in 28 patients (96.6%). The 30-day mortality rate was 6.9% (n = 2). During the median follow-up period of 44 (range, 0-152) months, no late aortic-related events attributable to the retained endograft components were observed. The estimated 5-year overall survival and freedom from aortic-related events were 88.9% and 93.1%, respectively.
CONCLUSION: The standardized partial explantation strategy was feasible in selected patients undergoing LOC for noninfectious EVAR failure and was associated with acceptable perioperative outcomes and mid- to long-term reconstructive durability even in a low-volume, real-world setting.